A majority of hepatocellular carcinoma (HCC) develops in the setting of persistent chronic inflammation as immunological mechanisms have been shown to play a vital role in the initiation, growth and progression of tumours. The index review has been intended to highlight ongoing immunological changes in the hepatic parenchyma responsible for the genesis and progression of HCC. The in-situ vaccine effect of radiofrequency (RF) is through generation tumour-associated antigens (TAAs), following necrosis and apoptosis of tumour cells, which not only re-activates the antitumour immune response but can also act in synergism with checkpoint inhibitors to generate a superlative effect with intent to treat primary cancer and distant metastasis. An im...
Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in chronically inflame...
HCC, the most prevalent form of primary liver cancer, is prototypically an inflammation-driven cance...
International audienceHepatocellular carcinoma (HCC) is the most common liver tumor and among the de...
A majority of hepatocellular carcinoma (HCC) develops in the setting of persistent chronic inflammat...
A majority of hepatocellular carcinoma (HCC) develops in the setting of persistent chronic inflammat...
Hepatocellular carcinoma (HCC) is the most common type of primary liver malignancy and the fourth le...
SummaryCurrent systemic treatment options for patients with hepatocellular carcinoma (HCC) are limit...
The global prevalence of liver cancer is rapidly rising, mostly as a result of the amplified inciden...
金沢大学がん進展制御研究所Tumor immunity proceeds through multiple processes, which consist of antigen presentati...
Hepatocellular carcinoma (HCC) is a common and serious health problem with high mortality. Treatment...
The incidence of liver cancer is continuously rising where hepatocellular carcinoma (HCC) remains th...
Immune associated cells in the microenvironment have a significant impact on the development and pro...
Background. Hepatocellular carcinoma is a major health problem worldwide and the third most common c...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC pa...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and confers a p...
Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in chronically inflame...
HCC, the most prevalent form of primary liver cancer, is prototypically an inflammation-driven cance...
International audienceHepatocellular carcinoma (HCC) is the most common liver tumor and among the de...
A majority of hepatocellular carcinoma (HCC) develops in the setting of persistent chronic inflammat...
A majority of hepatocellular carcinoma (HCC) develops in the setting of persistent chronic inflammat...
Hepatocellular carcinoma (HCC) is the most common type of primary liver malignancy and the fourth le...
SummaryCurrent systemic treatment options for patients with hepatocellular carcinoma (HCC) are limit...
The global prevalence of liver cancer is rapidly rising, mostly as a result of the amplified inciden...
金沢大学がん進展制御研究所Tumor immunity proceeds through multiple processes, which consist of antigen presentati...
Hepatocellular carcinoma (HCC) is a common and serious health problem with high mortality. Treatment...
The incidence of liver cancer is continuously rising where hepatocellular carcinoma (HCC) remains th...
Immune associated cells in the microenvironment have a significant impact on the development and pro...
Background. Hepatocellular carcinoma is a major health problem worldwide and the third most common c...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC pa...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and confers a p...
Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in chronically inflame...
HCC, the most prevalent form of primary liver cancer, is prototypically an inflammation-driven cance...
International audienceHepatocellular carcinoma (HCC) is the most common liver tumor and among the de...